Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

J&J Sprouts New Innovation Centers In Industry Hot Spots

Executive Summary

In an effort to expand outreach to and interaction with innovation-rich communities, J&J is creating four new regional innovation centers to act as scouts, deal-makers and alliance managers in Shanghai, Boston, California and London.

You may also be interested in...



Finding Cutting-Edge Science Takes A Broad Net, J&J Innovation’s Urban Says

Reflecting on the latest batch of deals, Global Head Robert Urban discusses the progress J&J Innovation has made so far and the next steps as it launches its JLINX incubator.

Deal Watch: Allergan Buys Kythera Anticipating Kybella Will Bolster Its Aesthetic Portfolio

Johnson & Johnson Innovation announces a spate of 17 deals, bringing its two-year total to more than 200 agreements. Celgene pays $82.5 million up front to partner with Kythera on a ROR gamma T program for cancer immunotherapy.

J&J Innovation Maintains Frenetic Deal-Making Pace With 17 New Agreements

Latest highlights include research collaboration to seek ways to intercept type 1 diabetes in its early stages; J&J’s four innovation centers have put together more than 200 partnerships in roughly two years.

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS054751

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel